Pharmafile Logo

How women are revolutionising rare disease

Women have played a crucial role in rare disease awareness and better care, overcoming gender biases and systemic challenges to drive progress in this often-overlooked field.

- PMLiVE

Historically, women have been marginalised with their needs often being unmet as compared with men — a situation mirrored to a greater degree in the rare disease sector as compared with common conditions. This field grapples both with gender disparities and the broader challenge of gaining recognition for rare diseases within healthcare systems.

Women leading rare disease advocacy

Women, who traditionally take on caregiving roles, have been at the forefront of rare disease advocacy. Empathy and strong communication skills make them effective as both caregivers and advocates. These roles are often assumed out of necessity when they notice symptoms in their children — a common situation as 70% of rare diseases first present in childhood.1 Women utilise various approaches to raise awareness, from kitchen table support groups to larger awareness campaigns to lobbying governments.

Women face additional delays due to
gender biases in the healthcare system.

You can read the full article here.

If you want to learn more about how Medscape Education is improving outcomes in rare diseases through education contact Christy Rohani-Montez. 

This content was provided by Medscape Education

Company Details

 Latest Content from  Medscape Education 

Contagious Conversations: Exploring Infectious Disease in the Digital Age

As the world of medicine continues to evolve, it's crucial to stay ahead of the curve. In this dynamic era, digital communications have emerged as a driving force in discussions...

Presenting Outstanding Outcomes from HCP Education in Multiple Myeloma at IMS in Athens

From September 27-30, members of the Medscape Education Global team were in Athens, Greece sharing 5 posters at the International Myeloma Society Annual Meeting, 2023.The posters presented the outcomes and...

Impacting Lives with Rare Disease Education

Education on rare diseases is crucial. Estimates suggest there are approximately 10,000 rare diseases, with 263–446 million people affected worldwide.Since its launch in September 2022, the Medscape Pathways in Rare...

Medscape’s Virtual Patient Simulation Makes a Significant Impact on Real-World Treatment Selection for T2D

An analysis of data using Real-World Outcomes showed that a virtual patient simulation had a significant effect on real-world treatment selection for T2D. The paper, published in JMIR Medical Education,...

A Rare Disease Update from Medscape Education

A Novel Provider Education Module to Enhance Detection of Alpha-1 Antitrypsin Deficiency

New Outcomes Are a Breath of Fresh Air at ERS

ERS 2023 will mark the new release of outcomes data by Medscape Education Global. During the poster hall sessions on September 12, the Medscape team will present a poster that...

Medscape Education Launches 20th Older Driver Safety Educational Program

Education Supported by the National Highway Traffic Safety Administration

Protecting the Heart Through Education at ESC 2023

Medscape Education Global is joining cardiology professionals from across Europe for ESC 2023 in Amsterdam. This year’s congress theme is “Joining Forces to Protect the Heart,” and Medscape will be...

Medscape’s Rare Disease Learning Center Has Reached 1 Million Learners

The Pathways in Rare Disease Learning Center celebrates a momentous achievement - engaging one million learners in its educational initiatives. This milestone signifies a profound impact on clinician confidence in...

Continuing Medical Education Outcomes are Much More Than Statistical Significance

At Medscape Education, we hold ourselves to the highest standards when it comes to analysing our programs. Our approach is unparalleled, employing a precise paired method that ensures we measure the...